Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors

This trial aimed to evaluate the efficacy of sirolimus in addition to cyclosporine (CSP) and mycophenolate mofetil (MMF) for graft-versus-host disease (GVHD) prophylaxis after nonmyeloablative conditioning for HLA class I or II mismatched hematopoietic cell transplantation (HCT). Eligible patients h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Kornblit, Brian, Storer, Barry E., Andersen, Niels S., Maris, Michael B., Chauncey, Thomas R., Petersdorf, Effie W., Woolfrey, Ann E., Flowers, Mary E. D., Storb, Rainer, Maloney, David G., Sandmaier, Brenda M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515688/
https://ncbi.nlm.nih.gov/pubmed/32603426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005338
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados